Rebecca Langhorn

Rebecca Langhorn

Auto-generated profile, based on publicly available information

Rebecca Langhorn

Department of Veterinary Clinical Sciences Faculty of Health & Medical Sciences University of Copenhagen Frederiksberg Denmark

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2016 in Journal of Veterinary Internal Medicine
Verified
Journal Article
Open access
PDF file
RLR. Langhorn
R. Langhorn
JWJakob Lundgren Willesen
Jakob Lundgren Willesen
Cardiac troponins are sensitive and specific markers of myocardial injury. The troponin concentration can be thought of as a quantitative measure of the degree of injury sustained by the heart, however, it provides no information on the cause of injury or the mechanism of troponin release. Conventionally, the cardiac troponins have been used for diagnosis of acute myocardial infarction in humans and have become the gold standard biomarkers for this indication. They have become increasingly recognized as an objective measure of cardiomyocyte status in both cardiac and noncardiac disease, supplying additional information to that provided by echocardiography and ECG. Injury to cardiomyocytes can occur through a variety of mechanisms with subsequent release of troponins. Independent of the underlying disease or the mechanism of troponin release, the presence of myocardial injury is associated with an increased risk of death. As increasingly sensitive assays are introduced, the frequent occurrence of myocardial injury is becoming apparent, and our understanding of its causes and importance is constantly evolving. Presently troponins are valuable for detecting a subgroup of patients with higher risk of death. Future research is needed to clarify whether troponins can serve as monitoring tools guiding treatment, whether administering more aggressive treatment to patients with evidence of myocardial injury is beneficial, and whether normalizing of troponin concentrations in patients presenting with evidence of myocardial injury is associated with reduced risk of death.

1 July 2013 in Journal of Veterinary Internal Medicine
Verified
Journal Article
Closed access
PDF file
RLR. Langhorn
R. Langhorn
MOM.A. Oyama
M.A. Oyama
LKL.G. King
L.G. King
MMM.C. Machen
M.C. Machen
DTD.J. Trafny
D.J. Trafny
MKM. Kjelgaard-Hansen
M. Kjelgaard-Hansen

16 October 2013 in Veterinary Clinical Pathology
Verified
Journal Article
Closed access
PDF file
RLRebecca Langhorn
Rebecca Langhorn
JWJakob Lundgren Willesen
Jakob Lundgren Willesen
ITInge Tarnow
Inge Tarnow
MKMads Kjelgaard‐Hansen
Mads Kjelgaard‐Hansen

1 September 2014 in Journal of Veterinary Internal Medicine
Verified
Journal Article
Open access
PDF file
RLR. Langhorn
R. Langhorn
ITI. Tarnow
I. Tarnow
JWJakob Lundgren Willesen
Jakob Lundgren Willesen
MKM. Kjelgaard-Hansen
M. Kjelgaard-Hansen
ISI.M. Skovgaard
I.M. Skovgaard
JKJørgen Koch
Jørgen Koch
Background: Myocardial injury detected by cardiac troponin I and T (cTnI and cTnT) in cardiac disease is associated with increased risk of death in humans and dogs. Hypothesis: Presence of myocardial injury predicts long-term death in cats with hypertrophic cardiomyopathy (HCM), and ongoing myocardial injury reflects change in left ventricular wall thickness over time. Animals: Thirty-six cats with primary HCM. Methods: Prospective cohort study. Cats with HCM were included consecutively and examined every 6 months. Echocardiography, ECG, blood pressure, and serum cTnI and cTnT were evaluated at each visit. Cox proportional hazards regression analysis was performed to evaluate prognostic potential of serum troponin concentrations at admission and subsequent examinations. Correlations were used to examine associations between troponin concentrations and cardiac hypertrophy. Results: Troponin concentrations at admission were median [range] 0.14 [0.004–1.02] ng/mL for cTnI, and 13 [13–79.5] ng/L for cTnT. Both were prognostic for death (P = .032 and .026) as were the last available concentrations of each (P = .016 and .003). The final cTnT concentration was a significant predictor of death even when adjusting for the admission concentration (P = .043). In a model containing both markers, only cTnT remained significant (P = .043). Left ventricular free wall thickness at end-diastole (LVFWd) at admission was correlated with cTnI at admission (r = 0.35, P = .035), however no significant correlations (r = 0.2–0.31, P = .074–.26) were found between changes in troponin concentrations and left ventricular thickness over time. Conclusions and Clinical Importance: Myocardial injury is part of the pathophysiology leading to disease progression and death. Low sensitivities and specificities prevent outcome prediction in individual cats.

1 February 2014
Verified
Journal Article
Closed access
MCMichelle B Christensen
Michelle B Christensen
RLRebecca Langhorn
Rebecca Langhorn
AGAmelia A. Goddard
Amelia A. Goddard
EAEva B Andreasen
Eva B Andreasen
EMElena Moldal
Elena Moldal
MKMads Kjelgaard-Hansen
Mads Kjelgaard-Hansen

4 December 2013 in Journal of Veterinary Emergency and Critical Care
Verified
Journal Article
Closed access
PDF file
RLRebecca Langhorn
Rebecca Langhorn
FPFrida Persson
Frida Persson
BÅBjörn Åblad
Björn Åblad
AGAmelia A. Goddard
Amelia A. Goddard
JSJohan Schoeman
Johan Schoeman
MKMads Kjelgaard‐Hansen
Mads Kjelgaard‐Hansen